The move indicated that the drug had cleared more rigorous hurdles since it was given emergency authorization in May.
0
Tag Archives: Drugs (Pharmaceuticals)
Trump Promised Seniors Drug Discount Cards. They May Be Illegal.
A proposal announced by President Trump last month was to send older Americans $200 discount cards to offset prescription costs. It’s not going to happen before the election, and maybe not ever.
0
Antibody Treatments, Though Promising, Will Be in Short Supply
All the weak points of American health care — testing delays, communication breakdowns, inequity — are working against this potential treatment.
0
Remdesivir Fails to Prevent Covid-19 Deaths in Huge Trial
Critics said the study, sponsored by the W.H.O., was too poorly conducted to be definitive.
0
Drug May Extend A.L.S. Patients’ Lives by Several Months, Study Finds
The two-drug combination invented by college students is one of many potential therapies being tested for this paralyzing fatal condition.
0
Eli Lilly’s Antibody Trial Is Paused Over Potential Safety Concern
The drugmaker’s experimental antibody treatment is similar to the one President Trump received from Regeneron.
0
Covid-19 Vaccines Offer Drug Makers Chance at Salvation, Financial and Beyond
Big profits beckon for pharmaceutical companies, which are already using their work on vaccines to fight efforts in Washington to curb drug prices.
0
The Race for a Super-Antibody Against the Coronavirus
A network of scientists is chasing the pandemic’s holy grail: an antibody that protects against not just the virus, but also related pathogens that may threaten humans.
0
A Dose of Optimism, as the Pandemic Rages On
The months ahead will be difficult. But the medical cavalry is coming, and the rest of us know what we need to do.
0
Can Trump Really Speed Approval of Covid Treatments?
Emergency-use authorizations, a formerly obscure corner of regulatory law, have become a centerpiece of the government’s response to the pandemic.
0
Trump’s Covid Treatments Were Tested in Cells Derived From Fetal Tissue
The “cell lines” used to develop monoclonal antibodies, as well as remdesivir and vaccines, began with fetal tissue decades ago.
0
With ‘Cure’ Comment, Trump Exaggerates Known Benefits of Another Covid-19 Therapy
An experimental antibody cocktail taken by the president has not yet been proven effective against the illness caused by the coronavirus.
0
Regeneron Asks F.D.A. for Emergency Approval for Drug That Trump Claimed Cured Him
The company said that doses of the unproven treatment would be available for 50,000 patients. It’s impossible to know whether it helped the president.
0
Trump Calls His Illness ‘a Blessing From God’
In a video on Wednesday evening, the president portrayed an unproven antibody cocktail being developed by the drug maker Regeneron as a miracle cure.
0
Hydroxychloroquine Is Part of the Online Conversation, Again
While the drug has not been shown to effectively treat Covid-19, many people on Twitter and Facebook urged President Trump to take it.
0
Trump’s Treatment Suggests Severe Covid-19, Medical Experts Say
Many of the measures cited by his doctors are reserved for patients severely affected by the coronavirus.
0
Against the Coronavirus, Imperfect Measures Do the Most Good
Speed and scale may matter more than absolute effectiveness when it comes to tests, masks, treatments and vaccines.
0
Trump’s Covid Treatments Suggest a Serious Condition
Outside experts pointed to the therapies as signs that the president’s health may not be as good as his doctors said. His age, weight and gender put him at high risk.
0
Will President Trump Get Antibody Treatments for Covid-19?
Regeneron and Eli Lilly wouldn’t say whether Mr. Trump would receive their experimental antibody drugs. Regeneron’s C.E.O. has known the president for years.
0
Could the Amazon Save Your Life?
Scientists are looking at the medicinal potential of plants and animals in the region’s vast tropical forests.
0
Will Pfizer’s Vaccine Be Ready in October? Here’s Why That’s Unlikely.
Despite slim chances that its vaccine will be ready by October, Pfizer has big incentives to hint that it might be.
0
Zinc: It Helps With Colds, But Not Coronavirus
Maybe! It may help with the common cold. There is no definitive scientific evidence suggesting it will help Covid-19.
0
Novavax Enters Final Stage of Coronavirus Vaccine Trials
The Maryland company, which has never brought a vaccine to market, has started its Phase 3 trial in the United Kingdom, with plans to begin in the United States in October.
0
Emails Show How Pesticide Industry Influenced U.S. Position in Health Talks
The U.S. insisted that new international guidelines on combating drug resistance omit any mention of fungicides — a demand that the industry made but that ran counter to science.
0
F.D.A. Requires Stronger Warning Label for Xanax and Similar Drugs
Benzodiazepines — commonly prescribed for anxiety, insomnia, seizures and panic disorders — are highly addictive and come with health risks, especially when combined with other drugs.
0
Johnson & Johnson Begins Phase 3 Trial of Covid-19 Vaccine
Unlike some of its competitors, Johnson & Johnson’s vaccine does not need to be frozen and may require just one shot instead of two.
0
When Will We See a Covid-19 Vaccine for Kids?
While scientists are rushing to develop an immunization for adults, no one has started the process yet for children.
0
For Older People, Reassuring News in the Statin Debate
There is accumulating evidence that the benefits of statins far outweigh possible risks, and nearly all statins on the market are now available as inexpensive generics.
0
A Deal on Drug Prices Undone by White House Insistence on ‘Trump Cards’
The White House and the pharmaceutical industry were nearing a major deal to lower drug prices. Then the administration demanded that $100 cash cards be sent to millions of seniors before the election — and the industry balked.
0
Eli Lilly Claims Experimental Drug Protects Covid-19 Patients
A so-called monoclonal antibody lowered levels of the coronavirus and prevented hospitalizations. The research has not yet been vetted by independent experts.
0
Trump Issues Expansive Order Aimed at Lowering Drug Prices
The order expands on a presidential promise by trying to reduce the prices Medicare pays for prescription drugs, but experts said it was unclear whether the White House could carry out the directive.
0
Vaccine Makers Keep Safety Details Quiet, Alarming Scientists
Researchers say drug companies need to be more open about how vaccine trials are run to reassure Americans who are skittish about getting a coronavirus vaccine.
0
Trump Pressed for a Plasma Treatment. Officials Worry, Is a Vaccine Next?
New details of how the president has demanded faster action from health agencies help explain the intensifying concern that he could demand pre-Election Day approval of a vaccine.
0
F.D.A. Regulators Publish Rare Self-Defense Amid Rising Vaccine Pressure
A group of career scientists at the Food and Drug Administration vowed that their work would continue unimpeded and independent of political influence.
0
Even Big Pharma Is Turning On Trump
The president is the Coronavirus vaccine’s worst hype man.
0
The Risks of the Prescribing Cascade
The problem occurs when drug-induced side effects are viewed as a new ailment and treated with yet another drug that can cause still other side effects.
0
‘Dwarf Pride’ Was Hard Won. Will a Growth Drug Undermine It?
An experimental medication that increases height in children with the most common form of dwarfism has raised hope that it can help them lead easier lives. But some say the condition is not a problem in need of a cure.
0
Pharma Companies Plan Joint Pledge on Vaccine Safety
The statement is meant to reassure the public that the companies will not seek a premature approval of vaccines under pressure from the Trump administration.
0
New Treatment for Lou Gehrig’s Disease Shows Promise
A study of their therapy and clinical trials of other experimental treatments are offering glimmers of hope that paralysis from the disorder can be slowed.
0
CDC Tells States How to Prepare for Covid-19 Vaccine by Early November
As President Trump pushes the possibility of a vaccine this year, the C.D.C. has outlined technical scenarios to state public health officials for an unidentified Vaccine A and Vaccine B.
0
We Don’t Know Enough About Convalescent Plasma
More than 70,000 Covid-19 patients have received it. We have no idea whether it helps.
0
In Hard Times, a Barrage of Ads Promises Peace of Mind
Meditation apps, tinctures, stress-busting gummies — spending on commercials for all of them is rising amid the pandemic’s climbing death toll and economic strain.
0
Emily Miller and Another P.R. Expert Ousted At F.D.A. After Blood Plasma Fiasco
The agency’s chief spokeswoman, Emily Miller, was removed from her position just 11 days into the job. And the contract was terminated of a consultant who had advised the F.D.A. chief to correct misleading claims about plasma’s benefits.
0
F.D.A. ‘Grossly Misrepresented’ Blood Plasma Data, Scientists Say
Many experts — including a scientist who worked on the Mayo Clinic study — were bewildered about where a key statistic came from.
0
Trump Keeps Promoting a Drug Order That No One Has Seen
The president’s campaign has made his efforts to lower prescription drug prices a centerpiece of his re-election pitch, but the executive order remains unseen.
0
Politicizing Medical Science Will Cost American Lives
Sowing doubt about the safety of treatments will imperil the fight against coronavirus in the months and years to come.
0
F.D.A. Allows Expanded Use of Convalescent Plasma to Treat Coronavirus Patients
The move came on the eve of the Republican convention and after President Trump pressed the agency to move faster to address the pandemic.
0
Oleandrin, Covid-19 Treatment Pitched to Trump, Could Be Dangerous
The chief executive of My Pillow, a Trump donor, claims oleandrin is a miracle cure for Covid-19. But no studies have shown that it is safe or effective, and the shrub it’s derived from is poisonous.
0
U.S. Mail Delays Slow Delivery of Medicines
In addition to concerns over mail-in voting, the cost-cutting at the Postal Service affects the millions of people who get their prescriptions by mail.
0